On December 12, 2025, the US Food and Drug Administration approved Johnson & Johnson subsidiary Janssen Biotech’s Akeega (niraparib and abiraterone acetate with prednisone for adults with deleterious ...

Swedish rare disease specialist Hansa Biopharma announced a reorganization of its European and International Commercial and ...

Japan’s Tanabe Pharma, formerly known as Mitsubishi Tanabe and now owned by Bain Capital, has obtained approval from the ...

M&A news last week featured Mirum Pharmaceuticals announcing plans to acquire fellow USA-based Bluejay Therapeutics and its ...

The European Medicines Agency’s (EMA) human medicines committee (CHMP) recommended five novel medicines for approval at its ...

The US Food and Drug Administration (FDA) on Friday announced it has approved two new oral medicines to treat a common ...

British pharma major AstraZeneca (LSE: AZN) has joined a near-$100 million series A and A+ financing round for Syneron Bio, a ...

Danish biotech Sidera Bio has raised about 700 million Kroner ($109 million) in a series A financing, one of the largest ...

New York, USA-based rare disease firm Applied Therapeutics has announced a definitive agreement to be acquired by privately-held UK-based Cycle Pharmaceuticals.

A major European pharmacy meeting that combines a professional congress with a large exhibition focused on medicines and ...

The US Food and Drug Administration (FDA) has approved its New Drug Application (NDA) for the use of an oral pellet ...

Medra, a US company developing the first platform for physical AI scientists, has announced a $52 million Series A financing.